BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF AND Prognosis
49 results:

  • 1. Dihydrotanshinone I exhibits antitumor effects via β-catenin downregulation in papillary thyroid cancer cell lines.
    Molteni E; Baldan F; Damante G; Allegri L
    Sci Rep; 2024 Apr; 14(1):7853. PubMed ID: 38570592
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Influence of advanced age on the prognosis of triple-negative breast cancer patients: A surveillance, epidemiology, and end results-based study.
    Tan H; Fu D
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147967
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment.
    Luo H; Xia X; Huang LB; An H; Cao M; Kim GD; Chen HN; Zhang WH; Shu Y; Kong X; Ren Z; Li PH; Liu Y; Tang H; Sun R; Li C; Bai B; Jia W; Liu Y; Zhang W; Yang L; Peng Y; Dai L; Hu H; Jiang Y; Hu Y; Zhu J; Jiang H; Li Z; Caulin C; Park J; Xu H
    Nat Commun; 2022 Nov; 13(1):6619. PubMed ID: 36333338
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Histocompatibility minor 13 (HM13), targeted by miR-760, exerts oncogenic role in breast cancer by suppressing autophagy and activating PI3K-AKT-mTOR pathway.
    Yang H; Li Z; Wang Z; Zhang X; Dai X; Zhou G; Ding Q
    Cell Death Dis; 2022 Sep; 13(8):728. PubMed ID: 36153332
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Retrospective study of the influence of hypothyroidism on liver function before radioiodine therapy in China: a comparison analysis based on patients with differentiated thyroid cancer.
    Ji Y; Zheng W; Meng Z; Wu C; Tan J; Wang R
    BMJ Open; 2022 Jan; 12(1):e045562. PubMed ID: 35042702
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Intraoperative airway management for patients with tracheal tumors: A case series of 37 patients.
    Gao R; Gu X; Zhang S; Ma S; Xu L; Li M; Gu L
    Thorac Cancer; 2021 Nov; 12(22):3046-3052. PubMed ID: 34626082
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Sustained response to imatinib in patient with extraskeletal myxoid chondrosarcoma and novel
    Jennings B; Rieth J; Snyders T; Milhem M
    BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34446510
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Collagen XI alpha 1 chain, a potential therapeutic target for cancer.
    Liu Z; Lai J; Jiang H; Ma C; Huang H
    FASEB J; 2021 Jun; 35(6):e21603. PubMed ID: 33999448
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A seven-nuclear receptor-based prognostic signature in breast cancer.
    Wu F; Chen W; Kang X; Jin L; Bai J; Zhang H; Zhang X
    Clin Transl Oncol; 2021 Jul; 23(7):1292-1303. PubMed ID: 33210236
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The extent of lymph node yield in central neck dissection can be affected by preoperative and intraoperative assessment and alter the prognosis of papillary thyroid carcinoma.
    Hu JQ; Wen D; Ma B; Zhang TT; Liao T; Shi X; Wang YL; Zhu YX; Wang Y; Wei WJ; Ji QH
    Cancer Med; 2020 Feb; 9(3):1017-1024. PubMed ID: 31854077
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Poorly differentiated thyroid carcinoma : An underdiagnosed entity.
    Dettmer MS; Schmitt A; Komminoth P; Perren A
    Pathologe; 2020 Jun; 41(Suppl 1):1-8. PubMed ID: 31273418
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Poorly differentiated thyroid carcinoma : An underdiagnosed entity. German version].
    Dettmer MS; Schmitt A; Komminoth P; Perren A
    Pathologe; 2019 May; 40(3):227-234. PubMed ID: 31093689
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. New scoring system for resectable hepatocellular carcinoma with a maximum tumor size of ≤5 cm based on preoperative tumor factors.
    Kawasaki Y; Yang SJ; Choi GH; Han DH; Lee JH; Iino S; Sakoda M; Ueno S; Natsugoe S; Choi JS
    HPB (Oxford); 2019 Oct; 21(10):1393-1399. PubMed ID: 30922846
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Treatment and surveillance of advanced, metastatic iodine-resistant differentiated thyroid cancer.
    Ibrahim EY; Busaidy NL
    Curr Opin Oncol; 2017 Mar; 29(2):151-158. PubMed ID: 28141684
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic Significance of the Proportion of Tall Cell Components in Papillary thyroid Carcinoma.
    Ito Y; Hirokawa M; Miyauchi A; Higashiyama T; Kihara M; Miya A
    World J Surg; 2017 Mar; 41(3):742-747. PubMed ID: 27807709
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Epigenetic silencing of the nr4a3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer.
    Yeh CM; Chang LY; Lin SH; Chou JL; Hsieh HY; Zeng LH; Chuang SY; Wang HW; Dittner C; Lin CY; Lin JM; Huang YT; Ng EK; Cheng AS; Wu SF; Lin J; Yeh KT; Chan MW
    Sci Rep; 2016 Aug; 6():31690. PubMed ID: 27528092
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT.
    Dettmer MS; Schmitt A; Steinert H; Capper D; Moch H; Komminoth P; Perren A
    Endocr Relat Cancer; 2015 Jun; 22(3):419-29. PubMed ID: 25870252
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A newly identified missense mutation in RET codon 666 is associated with the development of medullary thyroid carcinoma.
    Yamazaki M; Hanamura T; Ito K; Uchino S; Sakurai A; Komatsu M
    Endocr J; 2014; 61(11):1141-4. PubMed ID: 25319874
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Familial nonmedullary thyroid cancer: screening, clinical, molecular and genetic findings.
    Navas-Carrillo D; Ríos A; Rodríguez JM; Parrilla P; Orenes-Piñero E
    Biochim Biophys Acta; 2014 Dec; 1846(2):468-76. PubMed ID: 25218916
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.